BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34004329)

  • 1. Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture.
    Alshukairi AN; Tolah AM; Dada A; Al-Tawfiq JA; Almagharbi RS; Saeedi MF; Al-Hamzi MA; El-Kafrawy SA; Bahaudden HA; El-Saed A; Al-Mozaini MA; Khalid I; Hefni LK; Hassan AM; Alandijany TA; Bajrai LH; Bayumi DT; Albishi GE; Althawadi SI; Zabani NA; Perlman S; Azhar EI
    Int J Infect Dis; 2021 Jul; 108():112-115. PubMed ID: 34004329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.
    Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH
    Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.
    Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW
    BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: a systematic review.
    Jefferson T; Spencer EA; Conly JM; Rosca EC; Maltoni S; Brassey J; Onakpoya IJ; Evans DH; Heneghan CJ; Plüddemann A
    J Hosp Infect; 2023 Feb; 132():62-72. PubMed ID: 36473552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
    Hung IF; Cheng VC; Li X; Tam AR; Hung DL; Chiu KH; Yip CC; Cai JP; Ho DT; Wong SC; Leung SS; Chu MY; Tang MO; Chen JH; Poon RW; Fung AY; Zhang RR; Yan EY; Chen LL; Choi CY; Leung KH; Chung TW; Lam SH; Lam TP; Chan JF; Chan KH; Wu TC; Ho PL; Chan JW; Lau CS; To KK; Yuen KY
    Lancet Infect Dis; 2020 Sep; 20(9):1051-1060. PubMed ID: 32539986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
    Tarhini H; Recoing A; Bridier-Nahmias A; Rahi M; Lambert C; Martres P; Lucet JC; Rioux C; Bouzid D; Lebourgeois S; Descamps D; Yazdanpanah Y; Le Hingrat Q; Lescure FX; Visseaux B
    J Infect Dis; 2021 May; 223(9):1522-1527. PubMed ID: 33556961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
    Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N
    J Infect Chemother; 2021 Feb; 27(2):387-389. PubMed ID: 33328135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values.
    Thornton CS; Huntley K; Berenger BM; Bristow M; Evans DH; Fonseca K; Franko A; Gillrie MR; Lin YC; Povitz M; Shafey M; Conly JM; Tremblay A
    Antimicrob Resist Infect Control; 2022 Feb; 11(1):28. PubMed ID: 35123573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trajectories of the SARS-CoV-2 RNA load in patients with hematological malignancy.
    Mitsuyuki S; Nishikubo M; Shimomura Y; Ohyama Y; Maruoka H; Nasu S; Kubo T; Suzuki Y; Okada N; Nakagawa D; Kamijo K; Yamamoto R; Nagai Y; Hiramoto N; Yoshioka S; Yonetani N; Hasegawa K; Kuroda H; Hasuike T; Doi A; Kondo T; Ishikawa T
    Eur J Haematol; 2023 Jul; 111(1):57-62. PubMed ID: 36965014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 in Elderly, Immunocompromised or Diabetic Patients-From Immune Monitoring to Clinical Management in the Hospital.
    Wünsch K; Anastasiou OE; Alt M; Brochhagen L; Cherneha M; Thümmler L; van Baal L; Madel RJ; Lindemann M; Taube C; Witzke O; Rohn H; Krawczyk A; Jansen S
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Ct values in differentiating COVID-19 reinfection versus prolonged viral shedding in an immunocompromised patient.
    Julian K; Shah N; Banjade R; Bhatt D
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34315745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged viral shedding in an immunocompetent patient with COVID-19.
    McKie AM; Jones TPW; Sykes C
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33012717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged shedding of SARS-CoV-2 in an elderly liver transplant patient infected by COVID-19: a case report.
    Wei L; Liu B; Zhao Y; Chen Z
    Ann Palliat Med; 2021 Jun; 10(6):7003-7007. PubMed ID: 33183020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.
    Park SK; Lee CW; Park DI; Woo HY; Cheong HS; Shin HC; Ahn K; Kwon MJ; Joo EJ
    Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1387-1394.e2. PubMed ID: 32534042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds.
    Gniazdowski V; Paul Morris C; Wohl S; Mehoke T; Ramakrishnan S; Thielen P; Powell H; Smith B; Armstrong DT; Herrera M; Reifsnyder C; Sevdali M; Carroll KC; Pekosz A; Mostafa HH
    Clin Infect Dis; 2021 Aug; 73(4):e860-e869. PubMed ID: 33104776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center.
    Freeman MC; Rapsinski GJ; Zilla ML; Wheeler SE
    J Pediatric Infect Dis Soc; 2021 Apr; 10(4):426-431. PubMed ID: 33049042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 late shedding may be infectious between immunocompromised hosts.
    Kaila V; Sirkeoja S; Blomqvist S; Rannikko J; Viskari H; Lyly-Yrjänäinen T; Syrjänen J
    Infect Dis (Lond); 2021 Nov; 53(11):880-882. PubMed ID: 34137349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin's Lymphoma.
    Villaseñor-Echavarri R; Gomez-Romero L; Martin-Onraet A; Herrera LA; Escobar-Arrazola MA; Ramirez-Vega OA; Barrientos-Flores C; Mendoza-Vargas A; Hidalgo-Miranda A; Vilar-Compte D; Cedro-Tanda A
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical scoring system to predict viable viral shedding in patients with COVID-19.
    Kang SW; Park H; Kim JY; Park S; Lim SY; Lee S; Bae JY; Kim J; Bae S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Yun SC; Park MS; Kim SH
    J Clin Virol; 2022 Dec; 157():105319. PubMed ID: 36223658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.